Easy to crush
*Study evaluated different mechanical test procedures for assessing tablet chewability, including standard breaking force, strength testing, and new procedures simulating chewing action. A further objective was to apply these tests to assessing the chewability of various formulations of Velphoro compared with that of lanthanum-based and calcium-based phosphate binders.2
1. Velphoro® [package insert]. Waltham, MA: Fresenius Medical Care North America; 2018. 2. Lanz M, Baldischweiler J, Kriwet B, Schill J, Stafford J, Imanidis G. Chewability testing in the development of a chewable tablet for hyperphosphatemia. Drug Dev Ind Pharm. 2014;40(12):1623-1631.
Velphoro® (sucroferric oxyhydroxide) is a phosphate binder indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis.
For additional important safety information, please see the full Prescribing Information.
To report SUSPECTED ADVERSE REACTIONS, contact Fresenius Medical Care North America at
1-800-323-5188 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
This information is intended for use by US healthcare professionals only.